Feed/Investors/Shenzhen Angel FOF Management

Shenzhen Angel FOF Management

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-11-11

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$60.0M

across 1 round

LATEST ROUND

Series A · $60.0M · 2026-11-11

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Hangzhou Eli Radiopharma Co., Ltd. Eli Radiopharma specializes in the innovation of radioactive diagnostic and therapeutic drugs for cancer and neurodegenerative diseases.	Series A Verified against 4 of 12 sources	$60.0M	2026-11-11	[ PART ]